Level Chart

Basic Info

Eli Lilly & Co (LLY) - Diabetes Revenue is at a current level of 5.746B, up from 4.720B last quarter and up from 3.976B one year ago. This is a change of 21.72% from last quarter and 44.52% from one year ago.

Diabetes Revenue refers to the total revenue generated by Eli Lilly & Co from its products and treatments related to diabetes within a specific reporting period.

Region United States
Source FinChat.io

Data provided via FinChat.io

Stats

Last Value 5.746B
Latest Period Dec 2023
Last Updated Feb 29 2024, 08:53 EST
Next Release May 31 2024, 08:30 EDT (E)
Average Growth Rate 25.05%
Value from Last Quarter 4.720B
Change from Last Quarter 21.72%
Value from 1 Year Ago 3.976B
Change from 1 Year Ago 44.52%
Frequency Quarterly
Unit USD
Adjustment N/A

Historical Data

View and export this data back to 2019. Upgrade now.
Date Value
December 31, 2023 5.746B
September 30, 2023 4.720B
June 30, 2023 5.011B
March 31, 2023 4.190B
December 31, 2022 3.976B
September 30, 2022 3.663B
June 30, 2022 3.438B
March 31, 2022 3.388B
December 31, 2021 3.628B
Date Value
September 30, 2021 3.274B
June 30, 2021 3.176B
March 31, 2021 3.111B
December 31, 2020 3.304B
September 30, 2020 2.783B
June 30, 2020 2.779B
March 31, 2020 2.969B
December 31, 2019 2.342B

Basic Info

Eli Lilly & Co (LLY) - Diabetes Revenue is at a current level of 5.746B, up from 4.720B last quarter and up from 3.976B one year ago. This is a change of 21.72% from last quarter and 44.52% from one year ago.

Diabetes Revenue refers to the total revenue generated by Eli Lilly & Co from its products and treatments related to diabetes within a specific reporting period.

Region United States
Source FinChat.io

Data provided via FinChat.io

Stats

Last Value 5.746B
Latest Period Dec 2023
Last Updated Feb 29 2024, 08:53 EST
Next Release May 31 2024, 08:30 EDT (E)
Average Growth Rate 25.05%
Value from Last Quarter 4.720B
Change from Last Quarter 21.72%
Value from 1 Year Ago 3.976B
Change from 1 Year Ago 44.52%
Frequency Quarterly
Unit USD
Adjustment N/A

Related Securities

Symbol Name Change %
LLY Eli Lilly and Co -2.77%